{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:27:13Z","timestamp":1793741233957,"version":"4.6.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK124379"],"award-info":[{"award-number":["R01DK124379"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ekir.2026.107034","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:29:32Z","timestamp":1787239772000},"page":"107034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design and Baseline Characteristics of CONCORD, a Trial of Novel Therapies for Depression in CKD"],"prefix":"10.1016","volume":"11","author":[{"given":"Meredith C.","family":"McAdams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Parker","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Carmody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Trombello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynnel C.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Dubovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rula","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Roehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Shastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar H.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Susan","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.107034_bib1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.ajkd.2009.03.017","article-title":"Prevalence of major depressive episode in CKD","volume":"54","author":"Hedayati","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ki.2013.77","article-title":"Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies","volume":"84","author":"Palmer","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107034_bib3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/ki.2008.311","article-title":"Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression","volume":"74","author":"Hedayati","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107034_bib4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.ajkd.2005.07.002","article-title":"Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis","volume":"46","author":"Hedayati","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib5","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1001\/jama.2010.619","article-title":"Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death","volume":"303","author":"Hedayati","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.107034_bib6","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1046\/j.1523-1755.2000.00059.x","article-title":"Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients","volume":"57","author":"Kimmel","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107034_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.ajkd.2013.02.369","article-title":"Association between depression and death in people with CKD: a meta-analysis of cohort studies","volume":"62","author":"Palmer","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2215\/CJN.00030505","article-title":"Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality","volume":"1","author":"Boulware","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107034_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1542-4758.2012.00688.x","article-title":"Depression and nonadherence predict mortality in hemodialysis treated end-stage renal disease patients","volume":"16","author":"Rosenthal Asher","year":"2012","journal-title":"Hemodial Int"},{"key":"10.1016\/j.ekir.2026.107034_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2215\/CJN.0000000000000391","article-title":"Safety of antidepressant medications to treat comorbid depression in CKD: are we there yet?","volume":"19","author":"Hedayati","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107034_bib11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2215\/CJN.19891220","article-title":"Fatigue in CKD: epidemiology, pathophysiology, and treatment","volume":"16","author":"Gregg","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107034_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/j.ajkd.2009.05.003","article-title":"Epidemiology, diagnosis, and management of depression in patients with CKD","volume":"54","author":"Hedayati","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib13","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/sj.ki.5000308","article-title":"The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients","volume":"69","author":"Hedayati","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107034_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/ajkd.2003.50029","article-title":"The prevalence and treatment of depression among patients starting dialysis","volume":"41","author":"Watnick","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib15","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1523-1755.2004.00977.x","article-title":"Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS","volume":"66","author":"Lopes","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107034_bib16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.107034_bib17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","article-title":"Sertraline treatment of major depression in patients with acute MI or unstable angina","volume":"288","author":"Glassman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.107034_bib18","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1001\/jama.2016.7635","article-title":"Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial","volume":"315","author":"Angermann","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.107034_bib19","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1001\/jama.2017.17131","article-title":"Effect of sertraline on depressive symptoms in patients with chronic kidney disease without dialysis dependence: the CAST randomized clinical trial","volume":"318","author":"Hedayati","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.107034_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.biopsych.2005.04.030","article-title":"A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study","volume":"58","author":"Brown","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ekir.2026.107034_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2010.03.068","article-title":"Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial","volume":"56","author":"O\u2019Connor","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2026.107034_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MNH.0000000000000629","article-title":"Pharmacologic and psychological interventions for depression treatment in patients with kidney disease","volume":"29","author":"Gregg","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2026.107034_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/M18-2229","article-title":"Comparative efficacy of therapies for treatment of depression for patients undergoing maintenance hemodialysis: a randomized clinical trial","volume":"170","author":"Mehrotra","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2026.107034_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1681\/ASN.2012111134","article-title":"Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis","volume":"25","author":"Cukor","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107034_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2009.156","article-title":"Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients","volume":"76","author":"Duarte","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107034_bib26","first-page":"446","article-title":"Citalopram versus psychological training for depression and anxiety symptoms in hemodialysis patients","volume":"6","author":"Hosseini","year":"2012","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cct.2015.11.020","article-title":"Rationale and design of a trial of sertraline vs. cognitive behavioral therapy for end-stage renal disease patients with depression (ASCEND)","volume":"47","author":"Hedayati","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.ekir.2026.107034_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.semnephrol.2021.10.003","article-title":"Diagnosis and management of depression in patients with kidney disease","volume":"41","author":"Gregg","year":"2021","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2026.107034_bib29","article-title":"Efficacy of a behavioral activation teletherapy intervention to treat depression and anxiety in primary care VitalSign6 program","volume":"19","author":"Trombello","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.ekir.2026.107034_bib30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.beth.2020.01.002","article-title":"Two trajectories of depressive symptom reduction throughout behavioral activation teletherapy among underserved, ethnically diverse, primary care patients: a VitalSign(6) report","volume":"51","author":"Trombello","year":"2020","journal-title":"Behav Ther"},{"key":"10.1016\/j.ekir.2026.107034_bib31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cpr.2006.11.001","article-title":"Behavioral activation treatments of depression: a meta-analysis","volume":"27","author":"Cuijpers","year":"2007","journal-title":"Clin Psychol Rev"},{"issue":"Suppl 20","key":"10.1016\/j.ekir.2026.107034_bib32","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ekir.2026.107034_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ekir.2026.107034_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/j.ajkd.2009.03.016","article-title":"Validation of depression screening scales in patients with CKD","volume":"54","author":"Hedayati","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2025.07.020","article-title":"A practical primer on how to detect and treat depression in CKD","volume":"87","author":"Gregg","year":"2026","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cct.2012.10.004","article-title":"Rationale and design of the Chronic Kidney Disease antidepressant sertraline Trial (CAST)","volume":"34","author":"Jain","year":"2013","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.ekir.2026.107034_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/2045125316629071","article-title":"Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant","volume":"6","author":"Patel","year":"2016","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.ekir.2026.107034_bib38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0149-2918(00)88317-4","article-title":"A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline","volume":"21","author":"Croft","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.ekir.2026.107034_bib39","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0149-2918(01)80090-4","article-title":"A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine","volume":"23","author":"Coleman","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.ekir.2026.107034_bib40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4088\/JCP.v58n1204","article-title":"Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients","volume":"58","author":"Kavoussi","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ekir.2026.107034_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0893-133X(00)00249-9","article-title":"Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline","volume":"25","author":"Rush","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ekir.2026.107034_bib42","first-page":"329","article-title":"Double-blind comparison of bupropion and fluoxetine in depressed outpatients","volume":"52","author":"Feighner","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ekir.2026.107034_bib43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4088\/JCP.v67n0507","article-title":"Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies","volume":"67","author":"Clayton","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ekir.2026.107034_bib44","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.107034_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jad.2011.07.026","article-title":"A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression","volume":"136","author":"Rosso","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.ekir.2026.107034_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2190\/D235-2285-2121-6724","article-title":"Bupropion in the treatment of outpatients with asthma and major depressive disorder","volume":"37","author":"Brown","year":"2007","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.ekir.2026.107034_bib47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/pon.952","article-title":"An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners","volume":"15","author":"Moss","year":"2006","journal-title":"Psychooncol"},{"key":"10.1016\/j.ekir.2026.107034_bib48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1176\/ajp.148.4.512","article-title":"Cardiovascular effects of bupropion in depressed patients with heart disease","volume":"148","author":"Roose","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ekir.2026.107034_bib49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2017.12.007","article-title":"Management of traditional cardiovascular risk factors in CKD: what are the data?","volume":"72","author":"Gregg","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib50","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1093\/ndt\/gfs295","article-title":"Antidepressants for depression in stage 3\u20135 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP)","volume":"27","author":"Nagler","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.107034_bib51","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1037\/0022-006X.74.4.658","article-title":"Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression","volume":"74","author":"Dimidjian","year":"2006","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.ekir.2026.107034_bib52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(16)31140-0","article-title":"Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial","volume":"388","author":"Richards","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2026.107034_bib53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/1357633X13501767","article-title":"A systematic review of telecounselling and its effectiveness in managing depression amongst minority ethnic communities","volume":"19","author":"Dorstyn","year":"2013","journal-title":"J Telemed Telecare"},{"key":"10.1016\/j.ekir.2026.107034_bib54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/FCH.0b013e31820e0d99","article-title":"Use of technology to increase access to mental health services in a rural Texas community","volume":"34","author":"Wendel","year":"2011","journal-title":"Fam Community Health"},{"key":"10.1016\/j.ekir.2026.107034_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0145445510390929","article-title":"Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual","volume":"35","author":"Lejuez","year":"2011","journal-title":"Behav Modif"},{"key":"10.1016\/j.ekir.2026.107034_bib56","series-title":"Behavioral Activation for Depression: a Clinician\u2019s Guide","author":"Martell","year":"2022"},{"key":"10.1016\/j.ekir.2026.107034_bib57","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11255-018-1813-1","article-title":"Evaluation of quality of life, physical, and mental aspects in longevous patients with chronic kidney disease","volume":"50","author":"Martini","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ekir.2026.107034_bib58","series-title":"The Quality of Behavioral Activation Scale (Q-BAS)","author":"Dimidjian","year":"2016"},{"key":"10.1016\/j.ekir.2026.107034_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/wps.20089","article-title":"Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis","volume":"13","author":"Cuijpers","year":"2014","journal-title":"World Psychiatry"},{"key":"10.1016\/j.ekir.2026.107034_bib60","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/archpsyc.55.9.816","article-title":"Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings","volume":"55","author":"Fava","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ekir.2026.107034_bib61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000091771","article-title":"Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice","volume":"75","author":"Fava","year":"2006","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.ekir.2026.107034_bib62","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM200005183422001","article-title":"A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression","volume":"342","author":"Keller","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.107034_bib63","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.292.7.807","article-title":"Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial","volume":"292","author":"March","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.107034_bib64","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.299.8.901","article-title":"Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial","volume":"299","author":"Brent","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.107034_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4088\/JCP.v61n0112","article-title":"Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression","volume":"61","author":"Frank","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ekir.2026.107034_bib66","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.ekir.2026.107034_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00131746-200603000-00002","article-title":"Self-rated global measure of the frequency, intensity, and burden of side effects","volume":"12","author":"Wisniewski","year":"2006","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.ekir.2026.107034_bib68","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ekir.2019.12.009","article-title":"A systematic review and meta-analysis of depression and protein-energy wasting in kidney disease","volume":"5","author":"Gregg","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2026.107034_bib69","doi-asserted-by":"crossref","first-page":"436","DOI":"10.34067\/KID.0000062020","article-title":"Depression and the effect of sertraline on inflammatory biomarkers in patients with nondialysis CKD","volume":"1","author":"Gregg","year":"2020","journal-title":"Kidney360"},{"key":"10.1016\/j.ekir.2026.107034_bib70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.ajkd.2019.09.007","article-title":"Inflammation and response to sertraline treatment in patients with CKD and major depression","volume":"75","author":"Gregg","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib71","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2005020157","article-title":"Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients","volume":"16","author":"Weisbord","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107034_bib72","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000356939","article-title":"Prevalence and correlates of fatigue in chronic kidney disease and end-stage renal disease: are sleep disorders a key to understanding fatigue?","volume":"38","author":"Jhamb","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2026.107034_bib73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000500668","article-title":"Fatigue in nondialysis chronic kidney disease: correlates and association with kidney outcomes","volume":"50","author":"Gregg","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2026.107034_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration","volume":"5","author":"Kirsch","year":"2008","journal-title":"PLOS Med"},{"key":"10.1016\/j.ekir.2026.107034_bib75","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.ekir.2026.107034_bib76","series-title":"SAS for Mixed Models","author":"Stroup","year":"2006"},{"key":"10.1016\/j.ekir.2026.107034_bib77","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Med"},{"key":"10.1016\/j.ekir.2026.107034_bib78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/YIC.0b013e3282f2b4d6","article-title":"Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale","volume":"23","author":"Sheehan","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.ekir.2026.107034_bib79","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ekir.2026.107034_bib80","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/appi.ajp.2011.10111645","article-title":"Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study","volume":"168","author":"Rush","year":"2011","journal-title":"Am J Psychiatry"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926032663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926032663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:30:05Z","timestamp":1793737805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926032663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2468024926032663"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.107034","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and Baseline Characteristics of CONCORD, a Trial of Novel Therapies for Depression in CKD","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.107034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"107034"}}